Business Description
Fate Therapeutics is a San Diego-based clinical-stage biotech company focused on developing next-generation cell-based treatments for cancer and immune system disorders. Its pipeline includes several NK and T-cell therapies engineered to target specific diseases, ranging from blood cancers like B-cell lymphoma to complex autoimmune conditions such as lupus. The company works with Ono Pharmaceutical under a collaboration agreement to advance off-the-shelf cell therapies for solid tumors. Founded in 2007, Fate Therapeutics operates both in the United States and in international markets.
